Last Close
May 15  •  04:00PM ET
72.72
Dollar change
+0.11
Percentage change
0.15
%
May 14, 12:02 PMHenry Schein One's 2026 Catalyst Index release drives 3.88% gain on clinical performance data.
Index
S&P 500
P/E
21.96
EPS (ttm)
3.31
Insider Own
1.48%
Shs Outstand
114.42M
Perf Week
2.68%
Market Cap
8.28B
Forward P/E
12.31
EPS next Y
5.91
Insider Trans
-5.38%
Shs Float
96.57M
Perf Month
-5.82%
Enterprise Value
13.45B
PEG
1.32
EPS next Q
1.23
Inst Own
94.11%
Perf Quarter
-7.00%
Income
395.00M
P/S
0.62
EPS this Y
7.57%
Inst Trans
-6.24%
Perf Half Y
-0.16%
Sales
13.38B
P/B
2.55
EPS next Y
10.50%
ROA
3.63%
Perf YTD
-3.78%
Book/sh
28.54
P/C
60.03
EPS next 5Y
9.34%
ROE
12.01%
52W High
89.29 -18.56%
Perf Year
1.65%
Cash/sh
1.21
P/FCF
18.62
EPS past 3/5Y
-5.75% 3.12%
ROIC
6.75%
52W Low
61.94 17.39%
Perf 3Y
-7.02%
Dividend Est.
-
EV/EBITDA
12.16
Sales past 3/5Y
1.40% 5.43%
Gross Margin
29.19%
Volatility
3.14% 3.16%
Perf 5Y
-9.84%
Dividend TTM
-
EV/Sales
1.01
EPS Y/Y TTM
2.92%
Oper. Margin
5.88%
ATR (14)
2.32
Perf 10Y
7.89%
Dividend Ex-Date
-
Quick Ratio
0.75
Sales Y/Y TTM
5.64%
Profit Margin
2.95%
RSI (14)
46.98
Dividend Gr. 3/5Y
- -
Current Ratio
1.36
EPS Q/Q
4.63%
SMA20
-1.78%
Beta
0.81
Payout
0.00%
Debt/Eq
1.15
Sales Q/Q
6.31%
SMA50
-2.55%
Rel Volume
2.16
Prev Close
72.61
Employees
25000
LT Debt/Eq
0.79
SMA200
0.15%
Avg Volume
1.44M
Price
72.72
IPO
Nov 03, 1995
Option/Short
Yes / Yes
Trades
Volume
3,096,221
Change
0.15%
Date Action Analyst Rating Change Price Target Change
Apr-16-26Initiated BTIG Research Neutral
Apr-15-26Initiated Citigroup Buy $100
Feb-23-26Upgrade Robert W. Baird Neutral → Outperform $100
Dec-09-25Initiated Barclays Overweight $86
Aug-26-25Upgrade Evercore ISI In-line → Outperform $83
Jul-25-25Downgrade Stifel Buy → Hold $75
Jul-14-25Downgrade Robert W. Baird Outperform → Neutral $72
Feb-14-25Initiated Wells Fargo Equal Weight $80
Jan-06-25Upgrade BofA Securities Underperform → Buy $69 → $84
Dec-04-24Initiated Mizuho Neutral $75
May-14-26 06:30AM
May-05-26 12:51PM
10:55AM
06:06AM
06:00AM
06:30AM Loading…
May-04-26 06:30AM
Apr-30-26 06:30AM
Apr-28-26 10:04AM
Apr-21-26 06:30AM
Apr-20-26 12:12PM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-08-26 07:00AM
Apr-07-26 03:08PM
Mar-30-26 03:22AM
06:30AM Loading…
Mar-18-26 06:30AM
Mar-10-26 06:30AM
Mar-05-26 09:40AM
Mar-03-26 06:30AM
Mar-02-26 09:45AM
Feb-24-26 03:10PM
02:03PM
01:55PM
12:32PM
11:47AM
11:10AM
09:59AM
09:30AM
08:46AM
07:54AM
07:35AM Loading…
07:35AM
06:17AM
06:00AM
Feb-23-26 09:32AM
Feb-22-26 10:09PM
Feb-19-26 10:00AM
06:30AM
Feb-17-26 10:00AM
09:19AM
06:30AM
Feb-16-26 10:39AM
Feb-06-26 06:30AM
Jan-22-26 06:30AM
Jan-20-26 09:47AM
Jan-15-26 10:00AM
Jan-14-26 11:06PM
01:27PM
Jan-13-26 09:40AM
Jan-12-26 11:15AM
09:57AM
07:00AM
Jan-06-26 11:40AM
Jan-05-26 12:37AM
Dec-29-25 06:30AM
Dec-26-25 09:50AM
Dec-23-25 04:05PM
Dec-18-25 07:54AM
Dec-09-25 04:00PM
02:37PM
Dec-04-25 11:30AM
Dec-03-25 10:31PM
Dec-02-25 08:25AM
Dec-01-25 04:34PM
07:52AM
Nov-25-25 06:30AM
Nov-13-25 09:40AM
06:30AM
Nov-12-25 07:00AM
Nov-11-25 08:26AM
Nov-07-25 09:50AM
Nov-06-25 10:21PM
09:45AM
08:00AM
Nov-04-25 04:00PM
09:30AM
08:54AM
07:10AM
06:36AM
06:10AM
06:00AM
Nov-03-25 06:30AM
Nov-02-25 10:13PM
Oct-29-25 10:00AM
Oct-28-25 10:00AM
Oct-23-25 08:07AM
Oct-22-25 06:30AM
Oct-21-25 07:28AM
06:30AM
Oct-15-25 10:30AM
Oct-08-25 12:02AM
Sep-25-25 01:07PM
07:22AM
Sep-17-25 01:15PM
Sep-16-25 09:32AM
Sep-11-25 08:31AM
Sep-09-25 05:10PM
10:18AM
Aug-28-25 11:31PM
Aug-22-25 06:30AM
Aug-21-25 11:39AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Senior VP & CFOMr. Ronald N. South
Executive VP & COOMr. Michael Saul Ettinger
Executive VP & Chief Strategic OfficerMr. Mark E. Mlotek
Chief Executive Officer of Global Distribution & TechnologyMr. Andrea Albertini
CEO & DirectorMr. Frederick M. Lowery
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANIEL WILLIAM KDirectorMay 11 '26Buy69.1910,000691,90020,000May 12 04:15 PM
Popeck Thomas CCEO, Henry Schein ProductsMar 19 '26Sale72.791,35598,63086,182Mar 20 04:07 PM
Popeck Thomas COfficerMar 19 '26Proposed Sale72.791,35598,630Mar 19 12:30 PM
KUEHN KURT PDirectorMar 10 '26Sale78.962,844224,56515,420Mar 11 04:08 PM
KUEHN KURT PDirectorMar 10 '26Proposed Sale78.962,844224,565Mar 10 01:42 PM
MLOTEK MARK EEVP, Chief Strategic OfficerMar 04 '26Sale80.805,925478,74080,554Mar 06 06:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Sale80.362,844228,54421,961Mar 06 05:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Proposed Sale80.362,844228,544Mar 05 12:40 PM
MLOTEK MARK EOfficerMar 04 '26Proposed Sale80.805,925478,739Mar 04 04:28 PM
BERGMAN STANLEY MChairman, CEOMar 02 '26Sale81.3143,8123,562,354383,803Mar 03 08:18 AM
Stanley M. BergmanCEO, ChairmanMar 02 '26Proposed Sale82.3943,8123,609,671Mar 02 06:31 PM
BERGMAN STANLEY MChairman, CEOFeb 26 '26Sale81.0138,3463,106,591427,615Feb 27 04:31 PM
BERGMAN STANLEY MChairman, CEOFeb 27 '26Sale81.2010,785875,742309,092Feb 27 04:31 PM
Stanley M. BergmanCEO, ChairmanFeb 27 '26Proposed Sale81.4710,785878,654Feb 27 04:22 PM
Stanley M. BergmanOfficerFeb 26 '26Proposed Sale81.9143,0463,525,898Feb 26 04:25 PM
Siegel WalterOfficerNov 17 '25Proposed Sale71.304,176297,749Nov 17 10:29 AM
DANIEL WILLIAM KDirectorAug 07 '25Buy67.0810,000670,80010,000Aug 11 04:26 PM